SCHEMBL2911532

SCHEMBL2911532

C[C@H](CO)NC(=O)c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1-c1ccc(Cl)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
GSK3B P49841 4/20 0.40
GSK3A P49840 3/20 0.40
AHR P35869 2/20 0.37
CDK1 P06493 2/20 0.37
CCNB2 O95067 1/20 0.36
CCNB1 P14635 1/20 0.36
CCNB3 Q8WWL7 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
MITF O75030 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
NTSR1 P30989 1/20 0.35
CNR2 P34972 2/20 0.33
MAPK1 P28482 5/20 0.33
GAA P10253 1/20 0.33
HPGD P15428 1/20 0.33
FOLH1 Q04609 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2910371 1.00 ALDH1A1 (0.41) ALDH1A1SMN1; SMN2GSK3BGSK3AAHR
SCHEMBL2909788 0.93 GSK3B (0.34) ALDH1A1SMN1; SMN2GSK3BGSK3ACDK1
SCHEMBL2912533 0.93 GSK3B (0.34) ALDH1A1SMN1; SMN2GSK3BGSK3ACDK1
SCHEMBL2911906 0.92 CYP1A2 (0.34) ALDH1A1SMN1; SMN2GSK3BGSK3ACDK1
SCHEMBL2904127 0.92 MET (0.35) ALDH1A1SMN1; SMN2GSK3BGSK3ALMNA
SCHEMBL2904664 0.92 CYP1A2 (0.34) ALDH1A1SMN1; SMN2GSK3BGSK3ACDK1
SCHEMBL2911193 0.92 MET (0.35) ALDH1A1SMN1; SMN2GSK3BGSK3ALMNA
SCHEMBL2910313 0.92 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2GSK3BGSK3ACDK1
SCHEMBL2911799 0.92 ALDH1A1 (0.40) ALDH1A1SMN1; SMN2GSK3BGSK3ACDK1
SCHEMBL2911770 0.92 GSK3B (0.34) ALDH1A1SMN1; SMN2GSK3BGSK3AFOLH1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed